Curcumin binding to DNA and RNA

DNA and Cell Biology

Volumn 28, Issue 4, 2009, Pages 201-208

  Nafisi, Shohreh ^a   Adelzadeh, Maryam ^b   Norouzi, Zeinab ^a   Sarbolouki, Mohammad Nabi ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b Azad University   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; POLYNUCLEOTIDE; ANTINEOPLASTIC AGENT; CALF THYMUS DNA; DNA; FUNGAL RNA;

ARTICLE; DNA BINDING; DNA CONFORMATION; DNA DRUG COMPLEX; DRUG STRUCTURE; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; RNA BINDING; RNA CONFORMATION; ULTRAVIOLET SPECTROSCOPY; ANIMAL; CATTLE; CHEMISTRY; CONFORMATION; CURCUMA LONGA; INFRARED SPECTROPHOTOMETRY; METABOLISM;

CURCUMA LONGA;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; CURCUMA; CURCUMIN; DNA; NUCLEIC ACID CONFORMATION; RNA, FUNGAL; SPECTROPHOTOMETRY, INFRARED;

EID: 64549141066     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0840     Document Type: Article

References (56)

1. Ahmed Ouameur, A., and Tajmir-Riahi, H.A. (2004). Structural analysis of DNA interactions with biogenic polyamines and Cobalt(III)hexamine studied by Fourier transform infrared and capillary electrophoresis. J Biol Chem 279, 42041-42054.
2. Ahmed Ouamer, A., Marty, R., Neault, J.F., and Tajmir-Riahi, H.A. (2004a). AZT binds RNA at multiple sites. DNA Cell Biol 23, 783-788.
3. Ahmed Ouameur, A., Malogna, H., Neault, J.F., Diamantoglou, S., and Tajmir-Riahi, H.A. (2004b). Taxol interaction with DNA and RNA-stability and structural features. Can J Chem 82, 1112-1118.
4. Alaikov, T., Konstantinov, S.M., Tzanova, T., Dinev, K., Topashka-Ancheva, M., and Berger, M.R. (2007). Antineoplastic and anticlastogenic properties of curcumin. Ann NY Acad Sci 1095, 355-370.
5. Alex, S., and Dupuis, P. (1989). FT-IR and Raman investigation of cadmium binding by DNA. Inorg Chim Acta 157, 271-281.
6. Andrushchenko, V.V., Leonenko, Z., van de Sande, H., and Wieser, H. (2002). CD (VCD) and atomic force microscopy (AMF) study of DNA interactions with Cr3: VCD and AFM evidence of DNA condensation. Biopolymers 61, 243-260.
7. Arakawa, H., Ahmad, R., Naoui, M., and Tajmir-Riahi, H.A. (2000). A comparative study of calf thymus DNA binding to Cr(III) and Cr(VI) ions. J Biol Chem 275, 10150-10153.
8. Azuine, M.A., and Bhide, S.V. (1992). Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr Cancer 17, 77-83.
9. Azuine, M.A., and Bhide, S.V. (1994). Adjuvant chemopreven-tion of experimental cancer: catechin and dietary turmeric in forestomach and oral cancer models. J Ethnopharmacol 44, 211-217.
10. Bachmeier, B., Nerlich, A.G., Iancu, C.M., Cilli, M., Schleicher, E., Vene, R., Dell'Eva, R., Jochum, M., Albini, A., and Pfeffer, U. (2007). The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 19, 137-152.
11. Bemis, D.L., Katz, A.E., and Buttyan, R. (2006). Clinical trials of natural products as chemopreventive agents for prostate cancer. Expert Opin Investig Drugs 15, 1191-1200.
12. Bengmark, S. (2006). Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and in-ducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 30, 45-51.
13. Cheng, A.L., Hsu, C.H., Lin, J.K., Hsu, M.M., Ho, Y.F., Shen, T.S., et al. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21, 2895-2900.
14. Dean, J. (2003). Flavone: the molecular and mechanistic study of how a simple flavonoid protects DNA from oxidative damage. Ph.D. thesis, East Tennessee State University, Johnson City, TN.
15. Deeb, D., Jiang, H., Gao, X., Hafner, M.S., Wong, H., Divine, G., Chapman, R.A., Dulchavsky, S.A., and Gautam, S.C. (2004). Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-κB through suppression of IκBα phosphorylation. Mol Cancer Ther 3, 803-812.
16. DiRico, D.E., Keller, P.B., and Hartmann, K.A. (1985). The infrared spectrum and structure of the type-I complex of silver and DNA. Nucleic Acids Res 13, 251-260.
17. Duvoix, A., Blasius, R., Delhalle, S., Schnekenburger, M., Morceau, F., Henry, E., et al. (2005). Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223, 181-190.
18. Hass, R. (1992). Retrodifferentiation - an alternative biological pathway in human leukemia cells. Eur J Cell Biol 58, 1-11.
19. Hsu, C.H., Chuang, S.E., Hergenhahn, M., Kuo, M.L., Lin, J.K., Hsieh, C.Y., et al. (2002). Pre-clinical and early-phase clinical studies of curcumin as chemopreventive agent for endemic cancers in Taiwan. Gan To Kagaku Ryoho 29, 194-200.
20. Huang, T.S., Lee, S.C., and Lin, J.K. (1991). Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci USA 88, 5292-5296.
21. Huang, M.T., Lou, Y.R., Ma, W., Newmark, H.L., Reuhl, K.R., and Conney, A.H. (1994). Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54, 5841-5847.
22. Jiang, M.C., Yang-Yen, H.F., Yen, J.J., and Lin, J.K. (1996). Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer 26, 111-120.
23. Kamat, A.M., Sethi, G., and Aggarwal, B.B. (2007). Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-κB and nuclear factor- κB-regulated gene products in IFN-α-sensitive and IFN-α- resistant human bladder cancer cells. Mol Cancer Ther 1022-1030.
24. Kanakis, C.D., Tarantilis, P.A., Polissiou, M.G., Diamantoglou, S., and Tajmir-Riahi, H.A. (2005). DNA interaction with naturally occurring antioxidant flavonoids quercetin, kaempferol and delphinidin. J Biomol Struct Dyn 22, 719-724.
25. Kanakis, C.D., Tarantilis, P.A., Polissiou, M.G., Diamatoglou, S., and Tajmir-Riahi, H.A. (2007). An overview of DNA and RNA to antioxidant flavonoids. Cell Biochem Biophys 49, 29-36.
26. Karunagaran, D., Rashmi, R., and Kumar, T.R. (2005). Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets 5, 117-129.
27. Keller, P.B., and Hartman, K.A. (1986). The effect of ionic environment and mercury (II) on the alternative structures of DNA. An infrared spectroscopic study. Spectrochim Acta 42, 299-306.
28. Kunnumakkara, A.B., Guha, S., Krishnan, S., Diagaradjane, P., Gelovani, J., and Aggarwal, B.B. (2007). Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products. Cancer Res 67, 3853-3861.
29. Lambert, J.B., Shurvell, H.F., Lightner, D.A., and Cooks, R.G. (1998). Organic Structural Spectroscopy, Chapters 10-11 (Prentice-Hall, Hillsdale, NJ).
30. 2+ ions on calf thymus DNA: binding sites and conformational changes. Biopolymers 30, 743-752.
31. Lin, Y.G., Kunnumakkara, A.B., Nair, A., Merritt, W.M., Han, L.Y., Rmaiz-Pena, G.N., Kamat, A.A., Spannuth, W.A., Gershenson, D.M., Lutgendorf, S.K., Aggarwal, B.B., and Sood, A.K. (2007). Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-κB pathway. Clin Cancer Res 13, 3423-3430.
32. Lin C.L., and Lin J.K. (2008). Curcumin: a potential cancer che-mopreventive agent through suppressing NF-αB signaling. J Cancer Mol 4, 11-16.
33. Loprete, D.M., and Hartman, K.A. (1993). Conditions for the stability of the B, C and Z, structural forms of poly(dG-dC) in the presence of lithium, potassium, magnesium, calcium and zinc cations. Biochemistry 32, 4077-4082.
34. Maheshwari, R.K., Singh, A.K., Gaddipati, J., and Srimal R.C. (2006). Multiple biological activities of curcumin: a short review. Life Sci 78, 2081-2087.
35. Marmur, J. (1961). A procedure for the isolation of deoxyr-ibonucleic acid from microorganisms. J Mol Biol 3, 208-211.
36. Nafisi, Sh., Ghoreyshi Kahangi, F., Azizi, E., Zebarjad, N., and Tajmir-Riahi, H.A. (2007). Interaction of zanamivir with DNA and RNA: models for drug-DNA and drug-RNA bindings. J Mol Struct 830, 182-187.
37. Nafisi, Sh., Hashemi, M., Rajabi, M., and Tajmir-Riahi, H.A. (2008a). DNA adducts with antioxidant flavonoids. DNA Cell Biol 27, 433-442.
38. Nafisi, Sh., Saboury, A.A., Keramat, N., Neault, J.F., and Tajmir-Riahi, H.A. (2008b). Stability and structural features of DNA intercalation with ethidium bromide, acridine orange, meth-ylene blue. J Mol Struct 827, 35-43.
39. Nejedly, K., Chladkova, J., Vorlickova, M., Hrabcova, I., and Kypr, J. (2005). Mapping the B-A conformational transition along plasmid DNA. Nucl Acids Res 33, 1-8.
40. Nishino, H., Tokuda, H., Satom, I.Y., Masuda, M., Osaka, Y., Yogosawa, S., et al. (2004). Cancer prevention by antioxidants. Biofactors 22, 57-61.
41. Poluyanichko, A.M., Andrushchenko, V.V., Chikhirzhina, E.V., Vorob'Eb, V.I., and Wieser, H. (2004). The effect of manganese(II) on DNA structure: electronic and vibrational circular dichroism studies. Nucl Acids Res 32, 989-996.
42. Potaman, V.N., Bannikov, Y.A., and Shlyachtenko, L.S. (1980). Sedimentation of DNA in ethanol-water solution within the interval of B to A transition. Nucl Acids Res 8, 635-642.
43. Prescott, B., Steinmetz, W., and Thomas, G.J., Jr. (1984). Characterization of DNA structures by laser Raman spectroscopy. Biopolymers 23, 235-256.
44. Rao, C.V., Rivenson, A., Simi, B., and Reddy, B.S. (1995). Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55, 259-266.
45. Rashmi, R., Kumar, S., and Karunagaran, D. (2004). Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it. Carcinogenesis 25, 1867-1877.
46. Salvioli, S., Sikora, E., Cooper, E.L., and Franceschi, C. (2007). Curcumin in cell death processes: a challenge for CAM of age-related pathologies. eCAM 4, 181-190.
47. Sharma, R.A., Euden, S.A., Platton, S.L., Cooke, D.N., Shafayat, A., Hewitt, H.R., et al. (2004). Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10, 6847-6854.
48. Sharma, C., Kaur, J., Shishodia, S., Aggarwal, B.B., and Ralhan, R. (2006). Curcumin down regulates smokeless tobacco-induced NF-κB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology 228, 1-15.
49. Spiro, T.G. (1987). Biological Applications of Raman Spectroscopy (John Wiley & Sons, New York), pp. 83-133.
50. Starikov, E.B., Semenov, M.A., Maleev, V.Y., and Gasan, I.A. (1991). Evidential study of correlated events in biochemistry: physicochemical mechanisms of nucleic acid hydration as revealed by factor analysis. Biopolymers 31, 255-261.
51. Stephanos, J.J. (1996). Drug-protein interactions: two-site binding of heterocyclic ligands to a monomeric hemoglobin. J In-org Biochem 62, 155-169.
52. Taillandier, E., and Liquier, J. (1992). Infrared spectroscopy of DNA. Methods Enzymol 211, 307-335.
53. Tsuboi, M. (1969). Application of infrared spectroscopy to structure studies of nucleic acids. Appl Spectrosc Rev 3, 46-90.
54. Vijalakshmi, R., Kanthimathi, M., and Subramanian, V. (2000). DNA Cleavage by a Chromium(III) Complex. Biochem Biophys Res Commun 271, 731-734.
55. Zhong, W., Wang, Y., Yu, J.-S., Liang, Y., Ni, K., and Tu, S. (2004). The interaction of human serum albumin with a novel antidiabetic agent-SU-118. J Pharm Sci 93, 1039-1046.
56. Zsila, F., Bikádi Z., and Simonyi, M. (2004). Circular dichroism spectroscopic studies reveal pH dependent binding of curcumin in the minor groove of natural and synthetic nucleic acids. Org Biomol Chem 2, 2902-2910.